27 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34850494 | Daidzein exerts neuroprotective activity against MPTP-induced Parkinson's disease in experimental mice and lipopolysaccharide-induced BV2 microglial cells. | 2022 Feb | 1 |
2 | 35366203 | Protective Effect of CP690550 in MPTP-Induced Parkinson's Like Behavioural, Biochemical and Histological Alterations in Mice. | 2022 Apr | 1 |
3 | 33784949 | PGC-1α-siRNA suppresses inflammation in substantia nigra of PD mice by inhibiting microglia. | 2021 Jun 1 | 1 |
4 | 31732967 | MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1. | 2020 Mar | 1 |
5 | 32305864 | Validation of an in vivo electrochemical immunosensing platform for simultaneous detection of multiple cytokines in Parkinson's disease mice model. | 2020 Aug | 1 |
6 | 32376269 | Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model. | 2020 Jul 15 | 1 |
7 | 31251998 | Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice. | 2019 Sep 1 | 1 |
8 | 29363729 | (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease. | 2018 Apr | 1 |
9 | 26852411 | Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease. | 2017 Mar | 1 |
10 | 28182002 | Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease. | 2017 Feb 9 | 2 |
11 | 25637482 | Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease. | 2015 May | 1 |
12 | 24995576 | CNB-001, a novel pyrazole derivative mitigates motor impairments associated with neurodegeneration via suppression of neuroinflammatory and apoptotic response in experimental Parkinson's disease mice. | 2014 Sep 5 | 1 |
13 | 22772723 | IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration. | 2012 Dec | 2 |
14 | 20938211 | MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain. | 2011 | 1 |
15 | 21970803 | Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice. | 2011 Nov 30 | 1 |
16 | 20333481 | Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. | 2010 Oct | 1 |
17 | 20925384 | Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice. | 2010 Nov 10 | 1 |
18 | 17574387 | Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice. | 2007 Jul-Aug | 3 |
19 | 18196934 | Influence of age and gender on cytokine expression in a murine model of Parkinson's disease. | 2007 | 1 |
20 | 15589033 | Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. | 2005 Jan | 1 |
21 | 15804595 | Differential inflammatory activation of IL-6 (-/-) astrocytes. | 2005 Apr 21 | 2 |
22 | 15862160 | [Kinetic changes of plasma IL-1 and IL-6 levels in MPTP-induced Parkinson's disease model mice and their relationship with brain asymmetry]. | 2005 May | 3 |
23 | 15910760 | In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization. | 2005 May 31 | 2 |
24 | 16219171 | The levels of plasma IL-1beta, IL-6 of C57BL/6J mice treated with MPTP and brain lateralization. | 2004 Jun | 3 |
25 | 12957371 | Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice. | 2003 Sep 19 | 2 |
26 | 12358740 | Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. | 2002 Oct | 2 |
27 | 10499156 | Elevation of striatal interleukin-6 and serum corticosterone contents in MPTP-treated mice. | 1999 Sep | 3 |